Cyclooxygenase-2 expression is associated with elevated aspartate aminotransferase level in hepatocellular carcinoma | Zendy

AymanM Metwally | Zendy; Eman A. Bayomi | Zendy; A S T Barakat | Zendy; MahaA El-Bassuoni | Zendy; Randa Talaat | Zendy; MervatM El-Deftar | Zendy; SabrinA Abdel Wahab | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cyclooxygenase-2 expression is associated with elevated aspartate aminotransferase level in hepatocellular carcinoma

Author(s) -

AymanM Metwally,

Eman A. Bayomi,

A S T Barakat,

MahaA El-Bassuoni,

Randa Talaat,

MervatM El-Deftar,

SabrinA Abdel Wahab

Publication year - 2015

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.147692

Subject(s) - hepatocellular carcinoma , cyclooxygenase , medicine , gastroenterology , chemistry , enzyme , biochemistry

Cyclooxygenase-2 (COX-2), the inducible rate-limiting enzyme of prostaglandins biosynthesis, is involved in the pathogenesis of many chronic inflammation-related human malignancies including hepatocellular carcinoma (HCC). However, its clinical significance in HCC remains obscure. The aim of our study was to evaluate COX-2 expression in HCC and correlate its expression to both clinicopathological parameters and patients survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research